SCHEMBL9532256

SCHEMBL9532256

[C]1=CC2C=Cc3ccccc3C=C2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1040558 0.72
SCHEMBL21481153 0.55 NFKB1 (0.32)
SCHEMBL29375766 0.54 MAPT (0.53)
SCHEMBL29418986 0.54 MAPT (0.53)
SCHEMBL29398195 0.54
SCHEMBL3767165 0.54 MAPT (0.53)
SCHEMBL33554 0.54
Water SCHEMBL9798116 0.51 MAPT (0.50)
SCHEMBL8984812 0.51
Water SCHEMBL10406928 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0288196-B1 Sulfonyldecahydro-8H-isoquino[2,1-g][1,6]naphthyridines, optical isomers thereof and related compounds SYNTEX (U.S.A.) INC. (US) 1993-07-28 EP disclosed
US-5229387-A Cardiovascular disorders, alpha2-adenoreceptor antagonist or hydroxytryptamine receivers as hypotensive agents SYNTEX (U.S.A.) INC. (US) 1993-07-20 US disclosed
EP-0524004-A1 Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo[2,3-e]quinolizine derivatives SYNTEX (U.S.A.) INC. (US) 1993-01-20 EP disclosed
US-4956365-A ANTIDEPRESSANTS, ANTIANXIETY AGENTS, ANTICOAGULANTS, ANTIDIABETIC AGENTS SYNTEX (U.S.A.) INC. (US) 1990-09-11 US disclosed
US-4886798-A Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers SYNTEX (U.S.A.) INC. (US) 1989-12-12 US disclosed